Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study-Reference-Cited by-同舟云学术

Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study

Published:2016-11 Issue:11 Volume:48 Page:1314-1317
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Orlando Ambrogio,Renna Sara,Mocciaro Filippo,Cappello Maria,Giunta Marco,Mendolaro Marco,Mazza Marta,Rizzuto Giulia,Orlando Emanuele,Affronti Marco,Dimarco Mariangela,Di Mitri Roberto,Craxì Antonio,Cottone Mario

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis;Van Assche;Journal of Crohn's and Colitis,2010

2. Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease;Orlando;Digestive and Liver Disease,2011

3. Frequency of glucocorticoid resistance and dependency in Crohn's disease;Munkholm;Gut,1994

4. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease;Prefontaine;Cochrane Database of Systematic Reviews,2009

5. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

2. Clinical and genetic factors associated with clinical relapse during anti-tumor necrosis factor therapy in Japanese patients with Crohn’s disease;2022-10-25

3. Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients;European Journal of Gastroenterology & Hepatology;2021-03-19

4. Long-Term Prognosis of Japanese Patients with Crohn’s Disease Treated by Switching Anti-Tumor Necrosis Factor-α Antibodies;Inflammatory Intestinal Diseases;2019-12-20

5. Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies;Intestinal Research;2019-01-30